罗年安 董瑞 屈亚琦 李人立 张洪科.乳腺癌患者预后的相关因素分析[J].,2015,15(26):5056-5058 |
乳腺癌患者预后的相关因素分析 |
Analysis of the Related Factors of Breast Cancer Prognosis |
|
DOI: |
中文关键词: 乳腺癌 诊断 治疗 预后 |
英文关键词: Breast cancer Diagnosis Treatment Prognosis |
基金项目:国家自然科学青年基金项目(81001181) |
|
摘要点击次数: 817 |
全文下载次数: 0 |
中文摘要: |
目的:探讨影响乳腺癌患者预后的相关因素。方法:回顾性分析2008 年1 月~2009 年2 月我院收治的81 例乳腺癌患者的
临床、病理及随访资料。结果:所有患者均手术治疗并经病理证实,年龄45 岁以上的乳腺癌患者的五年生存率为82.6%,显著高
于45 岁及其以下者(45.7%,P<0.05);肿瘤直径为3 cm 及其以下的乳腺癌患者的五年生存率为81.5%,显著高于肿瘤直径为3 cm
以上者(40.7%,P<0.05);无淋巴结转移的乳腺癌患者五年生存率明显高于有淋巴结转移的乳腺癌患者(P<0.05);I 期、II期、Ⅲ期、
Ⅳ期的乳腺癌患者五年生存率分别为93.8%、73.0%、52.9%、0%,不同临床分期的乳腺癌患者的五年生存率比较差异均有统计
学意义(P<0.05)。结论:乳腺癌的治疗以手术为主,年龄、肿瘤大小、淋巴结转移、临床分期与患者的预后密切相关。 |
英文摘要: |
Objective:To investigate the related factors affecting the prognosis of patients with breast cancer.Methods:A retrospective
analysis was made on the clinical and pathological and follow-up data of 81 cases of breast cancer from Jan.2008 to Feb.2009 in
our hospital.Results:All the cases received surgical treatment and were pathologicallly confirmed, the 5-year survival rate of breast cancer
patients over 45 years old was 82.6%, which was significantly higher than those patients aged 45 years old and below (45.7%, P<0.
05). The 5-years survival rate of breast cancer patients whose tumor diameter were less than or equal to 3 cm was 81.5%, it was significantly
higher than those whose tumor diameter were greater than 3cm (40.7%, P<0.05). The 5-year survival rate of breast cancer patients
without lymph node metastases was significantly higher than those breast cancer patients with lymph node metastases in (P<0.05). The
5-year survival rates of breast cancer patients at stage I, stage II, stage Ⅲ, stage Ⅳ were 93.8%, 73%, 52.9%, 0%, significant differences
were found in the 5-year survival rates between breast cancer patients at different clinical stages (P<0.05).Conclusion:Breast cancer was
mainly treated by surgery, age, tumor size, lymph node metastasis, clinical stage were closely correlated with its prognosis. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |
|
|
|